Triclisia patens
Triclisia patens · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Triclisia patens is a botanical species that has garnered significant scientific interest due to its unique pharmacological properties. Research has highlighted its potent antiprotozoal activities, making it a subject of study in the field of ethnopharmacology. Specifically, the plant shows promise in targeting devastating pathogens such as Leishmania donovani. Furthermore, it has demonstrated effectiveness against Plasmodium falciparum, the primary parasite responsible for malaria. These findings suggest that the plant holds substantial potential for the development of new therapeutic treatments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Menispermaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Triclisia patens is a botanical species known by its common name, triklízia odstávajúca. This plant belongs to a unique group of flora that researchers study to better understand regional biodiversity. By recognizing its specific nomenclature, enthusiasts can more easily identify it within its natural habitat. Understanding these linguistic relationships helps bridge the gap between scientific classification and local usage. Such connections are essential for documenting the diverse life forms found across the globe.
Sources: Catalogue of Life (COL)
Taxonomy
Triclisia patens is a remarkable organism that belongs to the vast kingdom Plantae. Within this expansive biological group, it is classified under the class Equisetopsida. The plant is further organized into the order Ranunculales, showcasing its specific evolutionary lineage. It resides within the genus Triclisia, which defines its most immediate botanical relatives. Finally, its taxonomic journey concludes with its placement in the family Menispermaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Menispermaceae |
| Genus | Triclisia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Triclisia patens is a plant species primarily found throughout the diverse landscapes of West Tropical Africa. Its geographical footprint spans several key nations, including Burkina Faso and Ghana. The species also maintains a significant presence within the borders of Guinea and Guinea-Bissau. Furthermore, its distribution extends into the lush environments of the Ivory Coast. This widespread regional occurrence highlights the plant's adaptability to the various ecosystems found across the West African coast.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Triclisia patens is characterized by an obligatory climbing habit that allows it to navigate its environment effectively. While it relies on this climbing mechanism for support, the plant typically reaches a maximum height of only 10 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Triclisia patens has emerged as a highly significant plant species in recent pharmacological screenings for its potent antiprotozoal properties. During a study evaluating various extracts against Leishmania donovani and Trypanosoma brucei brucei, this plant demonstrated remarkable effectiveness. Specifically, Triclisia patens was identified as the most active specimen tested against Leishmania donovani. It achieved an impressive IC50 value of just 1.5 microg/ml, outperforming several other tested species. These findings highlight the plant's potential as a valuable source for developing new treatments against protozoal infections.
Compounds
Conditions
Triclisia patens demonstrates significant medicinal potential through its ability to treat various protozoan parasites. In studies screening for antiprotozoal activity, this plant emerged as the most effective extract against Leishmania donovani with an IC50 value of 1.5 microg/ml. Furthermore, research conducted on medicinal plants from Sierra Leone confirms its efficacy against Plasmodium falciparum. This specific plant was the only extract tested to show significant antiplasmodial activity, recording an IC50 of 8 microg/mL. Together, these findings highlight the dual therapeutic value of Triclisia patens against both Leishmania and Plasmodium species.